George S. G. Shehatou

Dr. George S. G. Shehatou


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MAMaged A. Abdel-Sayed
Maged A. Abdel-Sayed
SBSaid M. Bayomi
Said M. Bayomi
MEMagda A. El-Sherbeny
Magda A. El-Sherbeny
NANaglaa I. Abdel-Aziz
Naglaa I. Abdel-Aziz
KEKamal Eldin H. ElTahir
Kamal Eldin H. ElTahir
AAAlaa Abdel-Aziz
Alaa Abdel-Aziz

1 September 2020 in Life Sciences
Verified
Journal Article
Closed access
FAFatma M. Amin
Fatma M. Amin
RARania R. Abdelaziz
Rania R. Abdelaziz
MHMohamed F. Hamed
Mohamed F. Hamed
MNManar A. Nader
Manar A. Nader
GSGeorge S. G. Shehatou
George S. G. Shehatou

20 October 2015 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
GSGeorge S. G. Shehatou
George S. G. Shehatou
GSGhada M Suddek
Ghada M Suddek
The aim of the present work was to explore possible protective effects of sulforaphane (SFN) against atherosclerosis development and endothelial dysfunction in hypercholesterolemic rabbits. Rabbits were assigned to three groups of five: group I fed normal chow diet for four weeks, group II fed 1% high cholesterol diet (HCD) and group III fed HCD + SFN (0.25 mg/kg/day). Blood samples were collected for measurement of serum triglycerides (TGs), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), lactate dehydrogenase (LDH) and C-reactive protein (CRP). Aortic malondialdehyde (MDA), reduced glutathione (GSH), superoxide dismutase (SOD) and total nitrite/nitrate (NOx) were measured. Vascular reactivity and intima/media (I/M) ratio were analyzed. Nuclear factor-kappa B (NF-κB) activation in aortic endothelial cells was identified immunohistochemically. HCD induced significant increases in serum TGs, TC, LDL-C, LDH, and CRP, and aortic MDA and SOD. Moreover, HCD caused significant reductions in serum HDL-C, aortic GSH and NOx. SFN administration significantly decreased HCD-induced elevations in serum TC, LDL-C, CRP, and LDH. while significantly increased HDL-C and GSH levels and normalized aortic SOD and NOx. Additionally, SFN significantly improved rabbit aortic endothelium-dependent relaxation to acetylcholine. Moreover, SFN significantly reduced the elevation in I/M ratio. This effect was confirmed by aortic histopathologic examination. The expression of NF-κB in aortic tissue showed a marked reduction upon treatment with SFN. In conclusion, this study reveals that SFN has the ability to ameliorate HCD-induced atherosclerotic lesions progression and vascular dysfunction, possibly via its lipid-lowering and antioxidant effects and suppression of NF-κB-mediated inflammation.

1 May 2021 in Life Sciences
Verified
Journal Article
Closed access
NHNabila M.E. Hassan
Nabila M.E. Hassan
ESEman Said
Eman Said
GSGeorge S. G. Shehatou
George S. G. Shehatou

28 December 2015 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
AFAlaa N. A. Fahmi
Alaa N. A. Fahmi
GSGeorge S. G. Shehatou
George S. G. Shehatou
ASAbdelhadi M. Shebl
Abdelhadi M. Shebl
HSHatem A. Salem
Hatem A. Salem

1 June 2016 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
NSNoha M. Shawky
Noha M. Shawky
PPPrahalathan Pichavaram
Prahalathan Pichavaram
GSGeorge S. G. Shehatou
George S. G. Shehatou
GSGhada M. Suddek
Ghada M. Suddek
NGNariman M. Gameil
Nariman M. Gameil
LSLakshman Segar
Lakshman Segar